Correlation Between UMA and Injective

Can any of the company-specific risk be diversified away by investing in both UMA and Injective at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining UMA and Injective into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between UMA and Injective, you can compare the effects of market volatilities on UMA and Injective and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in UMA with a short position of Injective. Check out your portfolio center. Please also check ongoing floating volatility patterns of UMA and Injective.

Diversification Opportunities for UMA and Injective

0.97

Correlation Coefficient

UMA  Injective

Almost no diversification

The 3 months correlation between UMA and Injective is 0.97. Overlapping area represents the amount of risk that can be diversified away by holding UMA and Injective in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Injective and UMA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on UMA are associated (or correlated) with Injective. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Injective has no effect on the direction of UMA i.e., UMA and Injective go up and down completely randomly.

Pair Corralation between UMA and Injective

Assuming the 90 days trading horizon UMA is expected to generate 0.96 times more return on investment than Injective. However, UMA is 1.04 times less risky than Injective. It trades about -0.16 of its potential returns per unit of risk. Injective is currently generating about -0.15 per unit of risk. If you would invest  265.00  in UMA on December 30, 2024 and sell it today you would lose (146.00) from holding UMA or give up 55.09% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

UMA  vs.  Injective

UMA

Risk-Adjusted Performance

Very Weak

Over the last 90 days UMA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Crypto's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for UMA shareholders.

Injective

Risk-Adjusted Performance

Very Weak

Over the last 90 days Injective has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Crypto's forward-looking indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for Injective shareholders.

Pair Trading with UMA and Injective

The main advantage of trading using opposite UMA and Injective positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if UMA position performs unexpectedly, Injective can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Injective will offset losses from the drop in Injective's long position.

The idea behind UMA and Injective pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.